Your session is about to expire
← Back to Search
Low-Dose Aspirin for Postpartum Health
Study Summary
This trial will investigate how low-dose aspirin affects maternal health after giving birth. It will compare levels of NT-proBNP between those taking aspirin and those taking a placebo.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I have had bleeding in my stomach or intestines.I have had stomach or duodenal ulcers in the past.I have severe liver problems.I have a bleeding disorder.I have heart issues with reduced pumping ability or I am on ACE inhibitors.
- Group 1: Treatment Group
- Group 2: Placebo Group
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there particular individuals who would be more beneficial to include in this research project?
"In order to be deemed eligible, patients must have high blood pressure and fall between 18 and 60 years of age. This clinical trial is searching for 90 participants in total."
Are enrollment opportunities for this experiment still accessible?
"According to data posted on clinicaltrials.gov, this medical study is no longer recruiting patients as it was initially published June 30th 2023 and last amended May 25th 2023. Nevertheless, there are 102 other studies that still have open enrolment periods right now."
Has Treatment Group obtained its regulatory clearance from the FDA?
"As this is a Phase 4 trial, and thus approved by the relevant authorities, Treatment Group was calculated to be a 3 on Power's safety scale."
Does the eligibility criteria for this trial include persons who are sixty or older?
"This medical study seeks to include individuals aged 18 or more and under 60."
Share this study with friends
Copy Link
Messenger